Chemo heart risk under the microscope in lymphoma patients
NCT ID NCT02916316
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 127 people with diffuse large B-cell lymphoma who were treated with a common chemotherapy regimen called R-CHOP. The main goal was to track how often heart problems occurred as a side effect of the treatment. Researchers also looked at how well the cancer responded and overall survival. The study did not test a new treatment but rather observed real-world outcomes to better understand heart risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona
Ancona, 60126, Italy
-
A.O. Universitaria Policlinico Di Modena
Modena, MO, 41124, Italy
-
AO Riuniti Papardo Piemonte
Messina, ME, 98158, Italy
-
AOU Universitа degli Studi della Campania Luigi Vanvitelli
Naples, Italy
-
ASST Grande Ospedale Metropolitano Niguarda
Milan, MI, 20162, Italy
-
Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova
Reggio Emilia, 50139, Italy
-
Ematologia e Trapianto Istituto Regina Elena IFO
Roma, Italy
-
Istituto Clinico Humanitas
Rozzano, MI, Italy
-
Istituto Oncologico Veneto
Padova, 35128, Italy
-
Nuovo Ospedale Di Sassuolo S.P.A.
Sassuolo, Modena, 41049, Italy
-
Osp.Sant'Eugenio Divisione di Ematologia
Roma, Italy
-
Ospedale Ca Foncello
Treviso, Italy
-
Ospedale Riuniti di Foggia
Foggia, Italy
-
Ospedale S. Giacomo di Castelfranco Veneto
Castelfranco Veneto, Italy
-
Ospedali Riuniti Villa Sofia - Cervello
Palermo, PA, 90146, Italy
-
U.O. Complessa di Ematologia Ospedale di Parma
Parma, 43100, Italy
-
UO Ematologia PO Vito Fazzi
Lecce, Italy
-
UO Ematologia e CTMO di Piacenza
Piacenza, PC, 29121, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can engineered immune cells tackle brain lymphoma?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a targeted pill boost Chemotherapy's punch against lymphoma?